2025-05-08

Over the past decade, blockchain has transformed how we handle finance, art, and data. Yet, the physical infrastructure that underpins our digital lives — compute, storage, bandwidth — remains largely centralized. DEPIChain emerges as a new paradigm, aiming to bring these real-world assets on-chain in a verifiable, shareable, and tradeable manner.
DEPIChain is not just a platform — it’s a bridge between physical assets and the crypto economy. Through the DPT token, it incentivizes a global community to provide, validate, and utilize infrastructure resources, powering a decentralized physical infrastructure network (DePIN) driven by the community.
DPT is the economic backbone of DEPIChain. Beyond being a medium of exchange, it anchors incentive systems, governance participation, and value flow. Through its PoS mechanism, DPT secures the network while encouraging node participation, project deployment, and resource sharing — forming a complete and sustainable value loop.

DEPIN DAO focuses on incubation, resource integration, and community governance. Smart Chain, with its high-performance blockchain infrastructure, provides the ideal foundation. Together, they offer end-to-end support — from project onboarding and resource deployment to on-chain governance and scaling.
DEPIChain’s roadmap begins with essential tools: cross-chain bridges, decentralized exchanges, and integrated wallets — ensuring real usability. Over time, the ecosystem will expand with smart contract templates, developer SDKs, and open APIs to drive participation and build a sustainable DePIN ecosystem.
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright2009-2020Fresh life